Stock listing
A3C4MS Stock Price, News, Filings & Events — Roivant Sciences Ltd.
Selected listing: A3C4MS · LSX · EUR · DE
This page tracks Roivant Sciences Ltd.'s A3C4MS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3C4MS:LSX. A3C4MS:LSX is the stock-level entry point for investors researching Roivant Sciences Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3C4MS:LSX
- Asset type
- Stock
- Market cap
- $25.07B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Roivant Sciences Ltd. A3C4MS:LSX stock context
This page tracks Roivant Sciences Ltd.'s A3C4MS:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3C4MS:LSX. A3C4MS:LSX is the stock-level entry point for investors researching Roivant Sciences Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Roivant Sciences Ltd.
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with I...
September 6, 2026
Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with...
September 6, 2026
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
August 27, 2026
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
July 23, 2026
Roivant Sciences : Annual Report for Fiscal Year Ending March 31, 2025 (Form 10-K)
May 20, 2026
Roivant Sciences Ltd. earnings calls
Roivant Sciences Ltd. (ROIV) Q1 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call
May 20, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call
February 6, 2026 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q1 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
Roivant Sciences Ltd. (ROIV) Q4 2024 Earnings Call
May 29, 2025 · Replay with transcript and chapters
Research Roivant Sciences Ltd.
Roivant Sciences Ltd. investor report
Review AI stock analysis and investor report context for A3C4MS:LSX.
Roivant Sciences Ltd. company profile
View the public company page for Roivant Sciences Ltd. on 6ix.
Roivant Sciences Ltd. news
Read company news and market updates connected to Roivant Sciences Ltd..
Roivant Sciences Ltd. investor events
Find investor webinars, events, and replay context for Roivant Sciences Ltd..
Alternate listings
ROIV:NASDAQ
US · USD
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:GETTEX
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:TRADEGATE
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
ROIV:BX
CH · CHF
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
A3C4MS:LS
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
ROIV:BOATS
US · USD
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:DUS
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:FWB
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:MUN
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.
87S:SWB
DE · EUR
Alternate listing for Roivant Sciences Ltd.; the primary context on this page is A3C4MS:LSX.